R. Goodwin

发表

Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

C. Rauch, T. Griffith, H. Walczak, 1999, Nature Medicine.

Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells

S. Reed, R. Nordan, P. Morrissey, 1989, The Journal of experimental medicine.

Murine thymocytes proliferate in direct response to interleukin-7.

S. Reed, R. Nordan, P. Morrissey, 1989, Blood.

Interleukin-7 is a growth factor of precursor B and T acute lymphoblastic leukemia.

T. Agthoven, R. V. van Gurp, T. V. van Agthoven, 1990, Blood.

The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death

Terry Farrah, T. Farrah, R. Goodwin, 1994, Cell.

Molecular cloning and biological characterization of NK cell activation‐inducing ligand, a counterstructure for CD48

G. Trinchieri, M. Kubin, W. Chin, 1999, European journal of immunology.

Functional analysis of TRAIL receptors using monoclonal antibodies.

C. Smith, C. Rauch, N. Boiani, 1999, Journal of immunology.

Fas ligand mediates activation-induced cell death in human T lymphocytes

C. Smith, F. Ramsdell, K. Schooley, 1995, The Journal of experimental medicine.

Characterization of the in vivo function of TNF‐α‐related apoptosis‐inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene‐deficient mice

L. Sedger, S. Kanaly, B. Gliniak, 2002, European journal of immunology.

Characterization of the bovine prolactin gene.

S. Camper, R. Lyons, F. Rottman, 1984, DNA.

Characterization and nucleotide sequence of the gene for the common alpha subunit of the bovine pituitary glycoprotein hormones.

C. Moncman, F. Rottman, R. Goodwin, 1983, Nucleic Acids Research.

Reverse signaling via CD30 ligand.

C. Smith, R. Goodwin, S. Wiley, 1996, Journal of immunology.

CD30 is a CD40-inducible molecule that negatively regulates CD40-mediated immunoglobulin class switching in non-antigen-selected human B cells.

P. Casali, H. Zan, R. Goodwin, 1998, Immunity.

CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.

C. Smith, F. Herrmann, V. Zagonel, 1996, The American journal of pathology.

Regulation of murine B cell growth and differentiation by CD30 ligand

C. Maliszewski, Craig A. Smith, R. Goodwin, 1995, European journal of immunology.

Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines

N. Boiani, Craig A. Smith, R. Goodwin, 1994 .

CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF

N. Copeland, N. Jenkins, G. Sutherland, 1993, Cell.

IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression.

J. Peschon, L. Sedger, R. Goodwin, 1999, Journal of immunology.

Pleiotropic Effects of the CD 30 Ligand on CD 30-Expressing Cells and Lymphoma Cell Lines

Williams, Douglas, Smith, 2002 .

Molecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factor

N. Copeland, N. Jenkins, C. Smith, 1991, Molecular and cellular biology.

T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor.

G. McFadden, C. Smith, C. Upton, 1991, Biochemical and biophysical research communications.

Moslecular and biological characterization of human 4‐1BB and its ligands

G. Sutherland, Craig A. Smith, R. Goodwin, 1994, European journal of immunology.

Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells.

C. Ware, C. Smith, T. Vanarsdale, 1991, Journal of immunology.

Characterization of the human CD27 ligand, a novel member of the TNF gene family.

R. V. van Lier, S. Lens, R. Hintzen, 1994, Journal of immunology.

Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis.

H. Deeg, M. Loken, E. Bryant, 2001, Blood.

Interleukin-7 retroviruses transform pre-B cells by an autocrine mechanism not evident in Abelson murine

D. Lynch, R. Goodwin, K. Weisser, 1991, Molecular and cellular biology.

Activity of TNF‐related apoptosis‐inducing ligand (TRAIL) in haematological malignancies

M. Andreeff, F. Cabanillas, A. Younes, 1997, British journal of haematology.

B cell IL-7. Human B cell lines constitutively secrete IL-7 and express IL-7 receptors.

T. Knobloch, R. Goodwin, M. Dayton, 1994, Journal of immunology.

A new cytokine receptor superfamily.

C. March, R. Idzerda, R. Goodwin, 1990, Trends in biochemical sciences.

The interleukin-7 receptor gene is at 5pl3

G. Sutherland, R. Goodwin, E. Baker, 1992, Human Genetics.

Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells.

C. Smith, M. Degli-Esposti, P. Smolak, 1997, Journal of immunology.

Specific induction of 80-kDa tumor necrosis factor receptor shedding in T lymphocytes involves the cytoplasmic domain and phosphorylation.

C. Ware, T. Vanarsdale, R. Goodwin, 1993, Journal of immunology.

Expression of three members of the TNF-R family of receptors (4-1BB, lymphotoxin-beta receptor, and Fas) in human lung.

R. Goodwin, P. Soler, A. Hance, 1998, The European respiratory journal.

c-erbB activation in avian leukosis virus-induced erythroblastosis: multiple epidermal growth factor receptor mRNAs are generated by alternative RNA processing

T. Nilsen, H. Kung, F. Rottman, 1986, Molecular and cellular biology.

Engagement of CD153 (CD30 Ligand) by CD30+ T Cells Inhibits Class Switch DNA Recombination and Antibody Production in Human IgD+ IgM+ B Cells1

S. Ely, P. Casali, H. Zan, 2000, The Journal of Immunology.

Inhibits Class Switch DNA Recombination and Antibody Production in Human IgD 1 IgM 1 B Cells 1

S. Ely, P. Casali, H. Zan, 2000 .

Human IgD Recombination and Antibody Production in T Cells Inhibits Class Switch DNA + CD 30 Engagement of CD 153 ( CD 30 Ligand ) by

S. Ely, H. Zan, R. Goodwin, 2000 .

Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines.

D. Williams, N. Boiani, R. Goodwin, 1994, Blood.

Human IL-7: a novel T cell growth factor.

R. Armitage, M. Cooper, R. Goodwin, 1989, Journal of immunology.

Cloning and characterization of a potentially protective antigen in lymphatic filariasis.

T. Nilsen, J. Kazura, R. Goodwin, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Using Monoclonal Antibodies Functional Analysis of TRAIL Receptors

C. Rauch, N. Boiani, T. Griffith, 1999 .

Functional expression of TRAIL by lymphoid and myeloid tumour cells

S. Zhao, M. Andreeff, Yan Wang, 1999, British journal of haematology.

Immortalization of primary murine B lymphocytes with oncogene-containing retroviral vectors.

R. Goodwin, K. Grabstein, K. Weisser, 1990, Current topics in microbiology and immunology.

Characterization of the human and murine IL-7 genes.

L. Brunton, R. Goodwin, D. Cosman, 1990, Journal of immunology.

Chromosomal location of the human tumor necrosis factor receptor genes.

G. Sutherland, D. Callen, R. Goodwin, 1991, Cytogenetics and cell genetics.

Interleukin-7: a new hematopoietic growth factor.

D. Williams, R. Goodwin, A. Namen, 1990, Progress in clinical and biological research.

Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.

C A Smith, C. Smith, V. Fung, 1993, Journal of immunology.

Cloning of the human and murine interleukin-7 receptors: Demonstration of a soluble form and homology to a new receptor superfamily

S. Ziegler, C. March, S. Dower, 1990, Cell.

c-erbB activation in ALV-induced erythroblastosis: novel RNA processing and promoter insertion result in expression of an amino-truncated EGF receptor

T. Nilsen, H. Kung, F. Rottman, 1985, Cell.

A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins.

C. Smith, S. Dower, Craig A. Smith, 1990, Science.

Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family

R. Dubose, M. Degli-Esposti, H. Walczak, 1997, The Journal of experimental medicine.

Molecular cloning of a ligand for the inducible T cell gene 4‐1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor

N. Copeland, N. Jenkins, C. Brannan, 1993, European journal of immunology.

Stimulation of B-cell progenitors by cloned murine interleukin-7

C. March, R. Goodwin, D. Cosman, 1988, Nature.

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain.

C. Smith, W. Dougall, M. Degli-Esposti, 1997, Immunity.

Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha.

C. Smith, C. Richards, P. Smolak, 1996, Virology.

TRAIL‐R2: a novel apoptosis‐mediating receptor for TRAIL

Henning Walczak, M. Gerhart, M. Degli-Esposti, 1997, The EMBO journal.

Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor

G. Sutherland, T. Farrah, Craig A. Smith, 1993, Cell.

Immortalization of murine B cells in vitro with oncogene-containing retroviral vectors.

R. Goodwin, K. Grabstein, K. Weisser, 1992, Journal of immunology.

Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines.

H. Drexler, C. Uphoff, R. Goodwin, 1994, Leukemia.

Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells.

R. Goodwin, D. Cosman, S. Lupton, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Expression of Tumour Necrosis Factor (TNF)-related Apoptosis-Inducing Ligand (TRAIL) Receptors and Sensitivity to TRAIL-induced Apoptosis in Primary B-cell Acute Lymphoblastic Leukaemia Cells

U. Jaeger, A. Younes, H. Gadner, 2000 .

Expression of tumour necrosis factor (TNF)‐related apoptosis‐inducing ligand (TRAIL) receptors and sensitivity to TRAIL‐induced apoptosis in primary B‐cell acute lymphoblastic leukaemia cells

U. Jaeger, A. Younes, H. Gadner, 2000, British journal of haematology.

Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors.

M. Gerhart, C. Smith, D. Friend, 1997, Virology.

A lymphotoxin-beta-specific receptor.

C. Ware, C. Smith, J. Browning, 1994, Science.

Lymphopoiesis and IL-7.

J. Watson, P. Morrissey, R. Goodwin, 1990, International journal of cell cloning.

Distribution of m6A in mRNA and its Possible Biological Role

T. Nilsen, D. Ayers, S. Camper, 1986 .

TRAIL-R 2 : a novel apoptosis-mediating receptor for TRAIL et al . , 1980 ) and , together with cell proliferation , governs

M. Gerhart, A. Schooley, Richard S. Johnson, 2013 .

The TRAIL of Death

C. Smith, R. Goodwin, 1998, Apoptosis.

Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation.

W. Farrar, C. Smith, R. Goodwin, 1993, Proceedings of the National Academy of Sciences of the United States of America.

CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell line.

M. Hallek, B. Druker, B. Emmerich, 1995, Cancer research.

Identification and characterization of a new member of the TNF family that induces apoptosis.

C A Smith, C. Smith, G. Sutherland, 1995, Immunity.

The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster.

M R Alderson, C A Smith, K. Hunter, 1994, Immunity.

Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV‐1‐regulated protein gp34.

M. Seldin, G. Sutherland, F. Ramsdell, 1994, The EMBO journal.

Blood

R. Goodwin, Ruud, H. Hoogerbrugge, 2020, Definitions.

Moslecular and biological characterization of human 4‐1BB and its ligands

G. Sutherland, Craig A. Smith, R. Goodwin, 1994, European journal of immunology.